+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07855926

Real-World Evaluation of Perioperative Systemic Therapies in Muscle-Invasive Urothelial Carcinoma GUARDIANS Project Observational Registry

Led by LMU Klinikum · Updated on 2026-10-02

500

Participants Needed

1

Research Sites

126 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a multicenter observational registry study to collect real-world data on adults with muscle-invasive or locally advanced urothelial carcinoma of the bladder who receive perioperative systemic therapies. These therapies include combinations such as Enfortumab Vedotin plus Pembrolizumab, GemcitabineCisplatinDurvalumab, and other standard neoadjuvant or adjuvant treatments. The study aims to evaluate the feasibility, treatment tolerability, pathologic responses, and oncologic outcomes of these treatments in routine clinical care. Participants receive perioperative systemic therapies as part of standard care without any study-assigned interventions. Treatments and surgeries, including radical cystectomy with pelvic lymph node dissection, are performed according to local clinical practice. The registry includes both prospective and retrospective data collection, with information gathered on treatment completion, delays, modifications, and reasons for discontinuation. Patient-reported symptoms of neurotoxicity are also assessed using standardized questionnaires. Throughout the study, clinical data are collected pseudonymized via electronic case report forms from participating centers. Participants are followed from diagnosis through neoadjuvant therapy, surgery, adjuvant therapy when applicable, and long-term follow-up. Researchers evaluate event-free survival, pathologic complete response, disease-free survival, overall survival, treatment-related toxicities, postoperative complications, and patient-reported peripheral neuropathy symptoms over several months to years after treatment initiation.

CONDITIONS

Brief Title

Perioperative Systemic Therapies in Muscle-Invasive Bladder Cancer (GUARDIANS)

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here